Cargando…
Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: Thi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745999/ https://www.ncbi.nlm.nih.gov/pubmed/29282093 http://dx.doi.org/10.1186/s13054-017-1903-y |
_version_ | 1783289022625349632 |
---|---|
author | Christiansen, Søren Christensen, Steffen Pedersen, Lars Gammelager, Henrik Layton, J. Bradley Brookhart, M. Alan Christiansen, Christian Fynbo |
author_facet | Christiansen, Søren Christensen, Steffen Pedersen, Lars Gammelager, Henrik Layton, J. Bradley Brookhart, M. Alan Christiansen, Christian Fynbo |
author_sort | Christiansen, Søren |
collection | PubMed |
description | BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: This cohort study included all adult patients treated with continuous RRT in the ICU at Aarhus University Hospital, Skejby, Denmark (2005–2015). Data were obtained from a clinical information system and population-based registries. Early treatment was defined as RRT initiation at AKI stage 2 or below, and late treatment was defined as RRT initiation at AKI stage 3. Inverse probability of treatment (IPT) weights were computed from propensity scores. The IPT-weighted cumulative risk of CKD (estimated glomerular filtration rate < 60 ml/minute/1.73 m(2)), ESRD, and mortality was estimated and compared using IPT-weighted Cox regression. RESULTS: The mortality, CKD, and ESRD analyses included 1213, 303, and 617 patients, respectively. The 90-day mortality in the early RRT group was 53.6% compared with 46.0% in the late RRT group (HR 1.24, 95% CI 1.03–1.48). The 90-day to 5-year mortality was 37.7% and 41.5% in the early and late RRT groups, respectively (HR 0.95, 95% CI 0.70–1.29). The 5-year risk of CKD was 35.9% in the early RRT group and 44.9% in the late RRT group (HR 0.74, 95% CI 0.46–1.18). The 5-year risk of ESRD was 13.3% in the early RRT group and 16.7% in the late RRT group (HR 0.79, 95% CI 0.47–1.32). CONCLUSIONS: Early initiation was associated with increased 90-day mortality. In patients surviving to day 90, early initiation was not associated with a major impact on long-term mortality or risk of CKD and ESRD. Despite potential residual confounding due to the observational design, our findings do not support that early RRT initiation is superior to late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1903-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5745999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57459992018-01-03 Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury Christiansen, Søren Christensen, Steffen Pedersen, Lars Gammelager, Henrik Layton, J. Bradley Brookhart, M. Alan Christiansen, Christian Fynbo Crit Care Research BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: This cohort study included all adult patients treated with continuous RRT in the ICU at Aarhus University Hospital, Skejby, Denmark (2005–2015). Data were obtained from a clinical information system and population-based registries. Early treatment was defined as RRT initiation at AKI stage 2 or below, and late treatment was defined as RRT initiation at AKI stage 3. Inverse probability of treatment (IPT) weights were computed from propensity scores. The IPT-weighted cumulative risk of CKD (estimated glomerular filtration rate < 60 ml/minute/1.73 m(2)), ESRD, and mortality was estimated and compared using IPT-weighted Cox regression. RESULTS: The mortality, CKD, and ESRD analyses included 1213, 303, and 617 patients, respectively. The 90-day mortality in the early RRT group was 53.6% compared with 46.0% in the late RRT group (HR 1.24, 95% CI 1.03–1.48). The 90-day to 5-year mortality was 37.7% and 41.5% in the early and late RRT groups, respectively (HR 0.95, 95% CI 0.70–1.29). The 5-year risk of CKD was 35.9% in the early RRT group and 44.9% in the late RRT group (HR 0.74, 95% CI 0.46–1.18). The 5-year risk of ESRD was 13.3% in the early RRT group and 16.7% in the late RRT group (HR 0.79, 95% CI 0.47–1.32). CONCLUSIONS: Early initiation was associated with increased 90-day mortality. In patients surviving to day 90, early initiation was not associated with a major impact on long-term mortality or risk of CKD and ESRD. Despite potential residual confounding due to the observational design, our findings do not support that early RRT initiation is superior to late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1903-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-28 /pmc/articles/PMC5745999/ /pubmed/29282093 http://dx.doi.org/10.1186/s13054-017-1903-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Christiansen, Søren Christensen, Steffen Pedersen, Lars Gammelager, Henrik Layton, J. Bradley Brookhart, M. Alan Christiansen, Christian Fynbo Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title | Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title_full | Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title_fullStr | Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title_full_unstemmed | Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title_short | Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
title_sort | timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745999/ https://www.ncbi.nlm.nih.gov/pubmed/29282093 http://dx.doi.org/10.1186/s13054-017-1903-y |
work_keys_str_mv | AT christiansensøren timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT christensensteffen timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT pedersenlars timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT gammelagerhenrik timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT laytonjbradley timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT brookhartmalan timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury AT christiansenchristianfynbo timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury |